Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up (Q46692133)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up |
scientific article |
Statements
1 reference
Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up (English)
1 reference
Mitsune Tanimoto
1 reference
Atae Utsunomiya
1 reference
Shin Fujisawa
1 reference
Hirohisa Nakamae
1 reference
Michinori Ogura
1 reference
Ken-ichi Ishizawa
1 reference
Masafumi Taniwaki
1 reference
Kosei Matsue
1 reference
Yasushi Takamatsu
1 reference
Kensuke Usuki
1 reference
Yoji Ishida
1 reference
Hideki Akiyama
1 reference
Shintaro Onishi
1 reference
20 December 2013
1 reference
99
1 reference
2
1 reference
141-153
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference